Viewing Study NCT01472627


Ignite Creation Date: 2025-12-25 @ 5:07 AM
Ignite Modification Date: 2025-12-26 @ 4:11 AM
Study NCT ID: NCT01472627
Status: COMPLETED
Last Update Posted: 2018-01-11
First Post: 2011-08-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Effects of Bortezomib-Based Therapy on Cellular Immunity and Response to DC/Myeloma Fusion Vaccines in Vitro
Sponsor: Dana-Farber Cancer Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module